CLOSE

Specials

  • March
  • June
  • September
  • Bioanalytical Services
  • Life Science Analytics
  • Life Science Compliance
  • Bioanalytical Services APAC
  • APAC
  • Europe

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
APAC
  • Home
  • News
  • Contributors
  • Magazine
  • Conferences
  • Newsletter
  • About

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Principles of Sustainability in Pharmaceutical Packaging

Principles of Sustainability in...

How Life Sciences Companies Can Manage Compliance in Packaging

How Life Sciences Companies Can...

Innovation in Clinical Research in Times of COVID

Innovation in Clinical Research in...

Why Pharma Companies Must Adopt Veeva CRM Engage Meeting

Why Pharma Companies Must Adopt Veeva...

Ways Life Sciences Firms Can Build Streamlined and Compliant Artwork Packaging Process

Ways Life Sciences Firms Can Build...

The Evolving Role of Technology in Pharma

The Evolving Role of Technology in...

Bioanalytics- A New Ray of Hope

Bioanalytics- A New Ray of Hope

The Imperative Need for BI and CDS Tech in Healthace

The Imperative Need for BI and CDS...

Principles of Sustainability in Pharmaceutical Packaging

Principles of Sustainability in...

How Life Sciences Companies Can Manage Compliance in Packaging

How Life Sciences Companies Can...

Innovation in Clinical Research in Times of COVID

Innovation in Clinical Research in...

Why Pharma Companies Must Adopt Veeva CRM Engage Meeting

Why Pharma Companies Must Adopt Veeva...

Ways Life Sciences Firms Can Build Streamlined and Compliant Artwork Packaging Process

Ways Life Sciences Firms Can Build...

The Evolving Role of Technology in Pharma

The Evolving Role of Technology in...

Bioanalytics- A New Ray of Hope

Bioanalytics- A New Ray of Hope

The Imperative Need for BI and CDS Tech in Healthace

The Imperative Need for BI and CDS...

How Digital Manufacturing is Transforming Pharma Industry

By Jeremy Williams, Life Science Review | Monday, February 08, 2021
Tweet

The pharma companies are applying digital manufacturing to lower their expenses and increase quality.


FREMONT, CA: Nowadays, pharmaceutical managers are struggling with increasing uncertainty, expenses, and regulation, due to which more of them are looking at the development of Industry 4.0 as a solution. Data and machine learning operated by smart autonomous factories can lower pharmaceutical manufacturing expenses, increase quality, and decrease capacity constraints.


Most pharmaceutical companies have been slowly embracing digital manufacturing tools as they are concerned that their systems, data, and people were not ready. But several have concluded that further delay is not an option and have started to experiment with solutions from Industry 4.0. Pharmaceutical executives expect smart connected factories to generate savings of 20 percent or more, thus enhancing the quality and making deliveries more efficient. In particular, a 17 percent decrease in costs related to lower quality, a 15 percent reduction in the price of processing raw materials into drugs, and a 14 percent rise in delivery reliability.


Regulatory reforms, generic drug proliferation, and more personalized medicine put pharmaceuticals' profits at risk and make a strong case for digital production. Smaller but more frequent drug releases increase the difficulty and cost of production.


The advent of customized medicine with drugs made for each patient will lead to a complicated procedure. Moreover, the widespread utilization of generic drug use is driving prices down.


Production performance manager 


To generate an overview of the entire production system, including every unit's state, this solution collects near-real-time data from manufacturing equipment. Managers evaluating the system from end-to-end will easily detect issues and performance deficiencies. They can use data to understand the root causes. Implementing a production-performance manager will be easy for the businesses that already have a manufacturing execution system (MES) installed and utilize lean manufacturing techniques.


Advanced analytics for predictive maintenance 


Utilizing the data available from the sensor to identify breakdown patterns, like which part of the machine fails, the type of breakdown, and when this instrument can predict issues in advance. It offers production teams the opportunity to maintain machinery before it breaks down. The warning reduces manufacturing losses and helps to avoid costly repairs. Furthermore, optimizing the maintenance frequency also reduces its cost.


Weekly Brief

loading
Towards a New World Order
> <
  • Other 2021

    Top Vendors

    Current Issue
  • Other 2020

    Top Vendors

    Current Issue

Read Also

Top Biotech Developments to Watch for

Top Biotech Developments to Watch for

Importance of Biomarkers in Drug Development

Importance of Biomarkers in Drug Development

Using AI to Prevent Adverse Effects of Immunotherapy

Using AI to Prevent Adverse Effects of Immunotherapy

Ehave, Inc. Uses Artificial Intelligence And Machine Learning for Big Data Management in Mental Health Care

Ehave, Inc. Uses Artificial Intelligence And Machine Learning for Big Data Management in Mental Health Care
The Role of Technology in the Biotech Sector

The Role of Technology in the Biotech Sector

Why Partner with Bioanalysis Experts?

Why Partner with Bioanalysis Experts?

Cyberattacks in Hospitals

Cyberattacks in Hospitals

Principles of Sustainability in Pharmaceutical Packaging

Principles of Sustainability in Pharmaceutical Packaging
Loading...

Copyright © 2021 Life Science Review . All rights reserved. |  Subscribe follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/how-digital-manufacturing-is-transforming-pharma-industry-nwid-248.html